Tower Research Capital LLC (TRC) - DYNAVAX TECHNOLOGIES CORP ownership

DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 99 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q1 2015. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of DYNAVAX TECHNOLOGIES CORP
ValueSharesWeighting
Q3 2023$83,598
-39.4%
5,660
-47.0%
0.00%
-40.0%
Q2 2023$137,947
+241912.3%
10,677
+83.8%
0.01%
+150.0%
Q1 2023$57
-59.6%
5,810
-56.0%
0.00%
-66.7%
Q4 2022$141
-99.9%
13,204
-10.4%
0.01%
+200.0%
Q3 2022$154,000
-43.4%
14,735
-31.7%
0.00%
-66.7%
Q2 2022$272,000
-25.1%
21,582
-35.6%
0.01%
+100.0%
Q1 2022$363,000
-11.5%
33,516
+15.1%
0.00%
-57.1%
Q4 2021$410,000
-60.8%
29,109
-46.5%
0.01%
-74.1%
Q3 2021$1,046,000
+1415.9%
54,443
+676.3%
0.03%
+1250.0%
Q2 2021$69,000
-68.6%
7,013
-68.6%
0.00%
-50.0%
Q1 2021$220,000
+18.3%
22,323
-46.7%
0.00%
-33.3%
Q4 2020$186,000
+26.5%
41,920
+23.5%
0.01%
+200.0%
Q3 2020$147,000
-26.5%
33,957
+50.3%
0.00%
-75.0%
Q2 2020$200,000
+952.6%
22,593
+568.4%
0.01%
+300.0%
Q4 2019$19,000
+375.0%
3,380
+594.0%
0.00%
Q1 2019$4,000
+100.0%
487
+235.9%
0.00%
Q3 2018$2,000
-96.2%
145
-95.7%
0.00%
-100.0%
Q2 2018$52,000
+160.0%
3,411
+225.2%
0.00%0.0%
Q4 2017$20,000
-70.6%
1,049
-67.1%
0.00%
-50.0%
Q3 2017$68,000
+240.0%
3,187
+53.4%
0.01%
+200.0%
Q2 2017$20,000
+100.0%
2,078
+23.7%
0.00%
+100.0%
Q1 2017$10,000
+233.3%
1,680
+140.0%
0.00%
Q4 2016$3,000
-86.4%
700
-39.7%
0.00%
-100.0%
Q1 2016$22,000
+266.7%
1,161
+362.5%
0.00%
+200.0%
Q4 2015$6,000
+200.0%
251
+226.0%
0.00%
Q3 2015$2,000
-94.6%
77
-95.1%
0.00%
-100.0%
Q2 2015$37,000
-75.8%
1,578
-76.7%
0.00%
-84.2%
Q1 2015$153,000
+628.6%
6,787
+436.5%
0.02%
+850.0%
Q4 2014$21,0001,2650.00%
Other shareholders
DYNAVAX TECHNOLOGIES CORP shareholders Q1 2015
NameSharesValueWeighting ↓
Chicago Capital, LLC 5,791,735$85,543,9294.00%
Deep Track Capital, LP 6,756,956$99,800,2403.85%
Intrinsic Edge Capital Management LLC 1,133,099$16,735,8721.89%
Bain Capital Life Sciences Investors, LLC 915,000$13,514,5501.51%
Kynam Capital Management, LP 500,000$7,385,0001.21%
Rhenman & Partners Asset Management AB 700,000$10,339,0001.12%
AlphaCentric Advisors LLC 110,000$1,624,7000.92%
HighVista Strategies LLC 133,000$1,964,4100.91%
Affinity Asset Advisors, LLC 200,000$2,954,0000.83%
Rock Springs Capital Management LP 1,813,758$26,789,2060.72%
View complete list of DYNAVAX TECHNOLOGIES CORP shareholders